| Quarterly Financials | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 166 | 249 | 271 | 255 | 219 | 243 | 321 | 315 | 326 | 295 | 341 | 345 | 354 | 342 | 429 | 411 | 385 | 373 |
| Expenses | 132 | 168 | 177 | 160 | 164 | 155 | 204 | 200 | 219 | 200 | 215 | 218 | 236 | 237 | 270 | 264 | 255 | 249 |
| EBITDA | 34 | 80 | 94 | 95 | 54 | 88 | 117 | 115 | 107 | 96 | 125 | 127 | 118 | 106 | 158 | 148 | 129 | 124 |
| Operating Profit % | 20 % | 32 % | 34 % | 36 % | 23 % | 35 % | 35 % | 35 % | 31 % | 31 % | 35 % | 35 % | 31 % | 28 % | 35 % | 34 % | 31 % | 29 % |
| Depreciation | 20 | 19 | 21 | 21 | 22 | 22 | 23 | 23 | 23 | 25 | 27 | 28 | 32 | 34 | 35 | 35 | 34 | 34 |
| Interest | 13 | 13 | 12 | 12 | 16 | 14 | 13 | 14 | 14 | 15 | 13 | 14 | 17 | 18 | 18 | 18 | 18 | 18 |
| Profit Before Tax | 2 | 48 | 61 | 62 | 16 | 52 | 81 | 78 | 70 | 56 | 85 | 85 | 69 | 53 | 105 | 94 | 77 | 71 |
| Tax | 1 | 12 | 16 | 17 | 4 | 13 | 20 | 20 | 16 | 14 | 22 | 22 | 18 | 14 | 26 | 25 | 20 | 18 |
| Net Profit | 1 | 36 | 45 | 45 | 12 | 39 | 62 | 58 | 54 | 42 | 63 | 63 | 51 | 40 | 79 | 69 | 57 | 54 |
| EPS in ₹ | 0.14 | 3.91 | 4.87 | 4.79 | 1.36 | 3.78 | 6.06 | 5.74 | 5.31 | 4.04 | 6.20 | 6.12 | 5.02 | 3.89 | 7.77 | 6.76 | 5.55 | 5.27 |
Rainbow Childrens Medicare
Rainbow Childrens Medicare
1,525.10
-15.70
(-1.02%)
Q1 Quarterly Results are out. Check out the updated financials1 day ago
Show All
Market Cap
15,647.10 Cr
EPS
23.97
PE Ratio
60.63
Dividend Yield
0.20 %
Industry
Healthcare Services52 Week High
1,709.60
52 Week Low
1,129.00
PB Ratio
10.63
Debt to Equity
0.56
Sector
Hospitals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from7 analysts
Company News
View All News
Rainbow Children's Medicare Maintains 18-20% Revenue Growth Target Despite Seasonal Slowdown
1 day ago
1 day agoRainbow Children's Medicare has reaffirmed its revenue growth guidance of 18-20% for FY26, expecting demand to strengthen in upcoming quarters. The company posted a strong EBITDA margin of 29.4% in Q1 FY26 but will not revise its full-year guidance upward. Chairman and Managing Director Dr. Ramesh Kancharla indicated that margins may face pressure as three new hospitals with approximately 250 beds become operational this year. The company expects pre-Ind AS margins of 24-25% and post-Ind AS margins of 29-30% for FY26. Average revenue per patient is projected to grow 6% year-on-year, consistent with earlier projections. The rise in average revenue per occupied bed has been driven by stronger case mix including pediatric surgical, specialty, and quaternary care services like cardiac transplants and neurosurgeries. Surgical revenues demonstrated strong momentum with at least 15% growth in both volume and value. However, overall hospital occupancy declined to around 40% due to seasonal slowdown in outpatient and pediatric intensive care segments.
Rainbow Children's Medicare Reports Q1 FY26 Results; Appoints New Senior Management Personnel3 days ago
3 days agoRainbow Children's Medicare Limited announced its unaudited financial results for the quarter ended June 30, 2025. On a standalone basis, the company reported revenue from operations of Rs. 3,347.48 million and profit after tax of Rs. 517.20 million, with basic earnings per share of Rs. 5.09. On a consolidated basis, revenue from operations stood at Rs. 3,529.29 million with profit after tax of Rs. 538.05 million and basic earnings per share of Rs. 5.27. The board designated Dr. Pranathi Subrahmanyam Maddirala, Clinical Director of Obstetrics and Fetal Medicine, as Senior Management Personnel. The company also granted 140,810 stock options under ESOP 2025 to eligible employees and completed the acquisition of 76% equity stake in Prashanthi Medicare Private Limited for Rs. 326 million. A final dividend of Rs. 3 per equity share for FY 2024-25 was paid on July 5, 2025.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,274.30 | #1 1,22,237.70 | 108.01 | 7,184.10 | 18.77 | 1,076 | 26.84 | 56.58 | |
7,456.00 | 1,05,775.20 | 73.16 | #1 21,794.00 | 14.74 | 1,513 | 60.41 | 57.81 | |
850.60 | 63,888.30 | 75.79 | 7,849.70 | 8.99 | 809 | -7.43 | 70.84 | |
1,982.60 | 40,694.40 | 51.05 | 5,482.98 | 10.96 | 807 | 3.41 | 52.00 | |
1,331.40 | 36,404.30 | 70.04 | 3,692.32 | #1 25.09 | 486 | -20.35 | 63.43 | |
749.85 | 30,852.70 | 81.93 | 3,035.10 | 12.94 | 409 | 48.39 | 58.64 | |
591.50 | 29,861.90 | 80.45 | 4,138.46 | 22.85 | #1 5,417 | #1 3,986.36 | 50.04 | |
1,525.10 | #8 15,647.10 | #3 60.63 | #9 1,566.90 | #5 17.46 | #8 244 | #4 35.52 | 50.67 | |
1,439.20 | 9,431.00 | #1 49.93 | 1,290.20 | 17.77 | 194 | -0.88 | 38.22 | |
586.95 | 7,893.70 | 177.70 | 2,218.14 | 12.97 | 28 | -71.06 | 61.87 |
Automatic Screeners on ScanX
Forecast
Actual
Growth Rate
Revenue Growth
17.46 %
Net Income Growth
11.86 %
Cash Flow Change
23.11 %
ROE
-4.06 %
ROCE
3.26 %
EBITDA Margin (Avg.)
-1.17 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,771 | 2,170 | 2,377 |
| Fixed Assets | 78 | 123 | 174 | 296 | 702 | 702 | 772 | 858 | 931 | 1,253 | 1,398 |
| Current Assets | 98 | 171 | 125 | 73 | 133 | 203 | 197 | 290 | 478 | 622 | 822 |
| Capital Work in Progress | 35 | 31 | 7 | 12 | 23 | 43 | 29 | 6 | 23 | 20 | 29 |
| Investments | 7 | 2 | 6 | 0 | 3 | 10 | 18 | 22 | 58 | 308 | 571 |
| Other Assets | 111 | 194 | 212 | 140 | 199 | 265 | 262 | 409 | 759 | 590 | 380 |
| Total Liabilities | 231 | 349 | 399 | 448 | 926 | 1,019 | 1,081 | 1,296 | 1,771 | 2,170 | 2,377 |
| Current Liabilities | 36 | 42 | 56 | 71 | 92 | 130 | 122 | 125 | 139 | 150 | 151 |
| Non Current Liabilities | 15 | 13 | 14 | 15 | 463 | 480 | 511 | 564 | 567 | 756 | 751 |
| Total Equity | 181 | 295 | 329 | 362 | 372 | 409 | 448 | 606 | 1,065 | 1,265 | 1,475 |
| Reserve & Surplus | 166 | 275 | 309 | 307 | 317 | 351 | 392 | 498 | 958 | 1,157 | 1,367 |
| Share Capital | 15 | 20 | 20 | 55 | 55 | 55 | 55 | 105 | 102 | 102 | 102 |
Cash Flow
| Cash Flow | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | -1 | 3 | 1 | -2 | 2 | 2 | -1 | 4 | 7 | -7 | 10 |
| Investing Activities | -113 | -20 | -107 | -33 | -42 | -117 | -117 | -83 | -175 | -465 | -227 | -268 |
| Operating Activities | 15 | 26 | 17 | 36 | 48 | 127 | 170 | 143 | 224 | 329 | 321 | 396 |
| Financing Activities | 98 | -7 | 93 | -1 | -8 | -9 | -52 | -61 | -44 | 143 | -102 | -118 |
Share Holding
| % Holding | Dec 2021 | May 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 63.70 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.83 % | 49.88 % | 49.85 % | 49.85 % | 49.85 % | 49.85 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 21.63 % | 22.32 % | 24.04 % | 24.78 % | 25.11 % | 25.12 % | 23.69 % | 23.59 % |
| DIIs | 0.00 % | 6.35 % | 6.55 % | 10.26 % | 13.90 % | 15.38 % | 15.35 % | 15.40 % | 15.62 % | 14.76 % | 13.80 % | 13.83 % | 13.87 % | 15.31 % | 15.44 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 19.03 % | 15.87 % | 13.24 % | 13.75 % | 13.29 % | 13.04 % | 11.92 % | 11.03 % | 10.40 % | 10.74 % | 10.40 % | 10.38 % | 10.34 % | 10.32 % |
| Others | 36.30 % | 24.79 % | 27.75 % | 26.67 % | 22.52 % | 21.50 % | 21.78 % | 1.22 % | 1.21 % | 0.97 % | 0.80 % | 0.80 % | 0.77 % | 0.79 % | 0.79 % |
| No of Share Holders | 146 | 2,43,189 | 1,66,064 | 91,530 | 79,224 | 75,611 | 74,690 | 79,187 | 80,471 | 77,152 | 78,557 | 77,524 | 78,764 | 79,092 | 80,320 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2 | 3 | 3 | 3 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.28 | 0.23 | 0.21 | 0.19 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 26 Jul 2025 |  Quarterly Result Announcement | NA | 26 Jul 2025 | 1,526.50 | 1,554.50 |
| 05 Jul 2025 |  Annual General Meeting | NA | 05 Jul 2025 | 1,352.30 | 1,599.40 |
| 28 Jun 2025 |  Dividend | ₹ 3.00 /share | 27 Jun 2025 | 1,352.30 | 1,512.95 |
| 24 May 2025 | Quarterly Result Announcement | NA | 24 May 2025 | 1,366.75 | 1,352.30 |
| 09 Feb 2025 | Quarterly Result Announcement | NA | 09 Feb 2025 | 1,423.75 | 1,383.95 |
| 27 Oct 2024 | Quarterly Result Announcement | NA | 27 Oct 2024 | 1,431.30 | 1,417.75 |
| 30 Jul 2024 | Annual General Meeting | NA | 30 Jul 2024 | 1,393.75 | 1,172.30 |
| 23 Jul 2024 | Dividend | ₹ 3.00 /share | 23 Jul 2024 | 1,393.75 | 1,145.75 |
| 22 Jun 2023 | Dividend | ₹ 3.00 /share | 22 Jun 2023 | 849.65 | 977.25 |
| 08 Sept 2022 | Dividend | ₹ 2.00 /share | 07 Sept 2022 | 489.05 | 611.60 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Investor Presentation3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release3 days ago
3 days agoGrant Of Stock Options3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Change in Management3 days ago
3 days agoBoard Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On July 26 20253 days ago
3 days agoUnaudited Financial Results For The Quarter Ended June 30 20253 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation7 days ago
7 days agoBoard Meeting Intimation for Approval Of Un-Audited (Standalone & Consolidated) Financial Results Of The Company For The Quarter Ended June 30 2025.8 days ago
8 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 07, 2025
Jul 07, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 05, 2025
Jul 05, 2025Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 01, 2025
Jul 01, 2025Announcement under Regulation 30 (LODR)-AcquisitionJun 28, 2025
Jun 28, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 21, 2025
Jun 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 14, 2025
Jun 14, 2025Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 13, 2025
Jun 13, 2025Business Responsibility and Sustainability Reporting (BRSR)Jun 13, 2025
Jun 13, 2025Reg. 34 (1) Annual Report.Jun 13, 2025
Jun 13, 2025Notice Of 27Th Annual General Meeting To Be Held On July 5 2025Jun 13, 2025
Jun 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2025
Jun 09, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJun 09, 2025
Jun 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 07, 2025
Jun 07, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 03, 2025
Jun 03, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 31, 2025
May 31, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2025
May 26, 2025Appointment Of Secretarial Auditor Internal Auditors & Cost Auditors Of The CompanyMay 24, 2025
May 24, 2025The Record Date For Payment Of The Final Dividend Has Been Fixed As June 28 2025May 24, 2025
May 24, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 24, 2025
May 24, 2025Corporate Action-Board approves DividendMay 24, 2025
May 24, 2025Convening Of 27Th AGM Of The Company On July 5 2025May 24, 2025
May 24, 2025Announcement under Regulation 30 (LODR)-Investor PresentationMay 24, 2025
May 24, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 24, 2025
May 24, 2025Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On May 24 2025May 24, 2025
May 24, 2025Audited Financial Results For The Quarter And Financial Year Ended March 31 2025May 24, 2025
May 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 17, 2025
May 17, 2025Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results For The Period Ended March 31 2025 And To Consider Recommending Final Dividend If Any.May 17, 2025
May 17, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2025
May 13, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Apr 11, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 03, 2025
Apr 03, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 06, 2025
Mar 06, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 04, 2025
Mar 04, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 03, 2025
Mar 03, 2025Update On Purchase Of Land Parcels Located In Sector 44 & Sector 56 Of Gurugram Haryana.Mar 01, 2025
Mar 01, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 15, 2025
Feb 15, 2025Technical Indicators
RSI(14)
Neutral 50.67
ATR(14)
Less Volatile 49.06
STOCH(9,6)
Neutral 39.46
STOCH RSI(14)
Oversold 16.02
MACD(12,26)
Bearish -4.47
ADX(14)
Strong Trend 32.54
UO(9)
Bearish 43.78
ROC(12)
Downtrend And Accelerating -0.65
WillR(14)
Oversold -82.77
Mutual Fund Holdings
HSBC Focused Fund Direct - Growth 
ICICI Prudential Midcap Direct Plan-Growth 
Kotak Healthcare Fund Direct - Growth 
UTI Healthcare Fund Direct-Growth 
Motilal Oswal Small Cap Fund Direct - Growth 
Bandhan Aggressive Hybrid Fund Direct-Growth 
Edelweiss Multi Cap Fund Direct - Growth 
Baroda BNP Paribas Health and Wellness Fund Direct-Growth 
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth 
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth 
HDFC Nifty Smallcap 250 Index Fund Direct-Growth 
SBI Nifty Smallcap 250 Index Fund Direct - Growth 
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth About Rainbow Childrens Medicare
Rainbow Children's Medicare Limited is a leading chain of multi-specialty pediatric, obstetrics, and gynecology hospitals in India. Originally incorporated in 1998, it operates 16 hospitals and three clinics across six cities, with a total bed capacity of 1,655. The company specializes in pediatric services, including newborn and pediatric intensive care, multi-specialty services, and quaternary care, as well as obstetrics and gynecology services. Founded by Dr. Ramesh Kancharla, Rainbow follows a full-time, exclusive doctor-led model of healthcare delivery. The company expanded its services over the years, establishing hospitals in various cities and introducing new specialties. In 2022, Rainbow completed an Initial Public Offering and its shares were listed on the National Stock Exchange of India Limited and BSE Limited. The company also offers post-graduate DNB and fellowship programs in pediatrics.
Listing Date
10 May, 2022(3 Years,
20 days)
Chairperson NameRamesh Kancharla
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
